[1] |
Xianli Qiao, Xiangyang Tian, Wenya Zhou, Zemin Qin, Shanshan Guo, Junyan Yu.
Significance of circulating tumor DNA in predicting postoperative recurrence risk of non-small cell lung cancer
[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2025, 18(03): 395-400.
|
[2] |
Yabo Zhao, Qian Wang, Xiaolong Yan, Yuanyong Wang, Gaihua He, Yize Guo.
Study on serum miR-21 and miR-937-3p expression changes in early stage non-small cell lung cancer patients before and after surgery
[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2025, 18(03): 345-349.
|
[3] |
Zhaolei You, Xiaoliang Jing, Liang Zong, Qingchao Sun, Desheng Li, Liwei Zhang.
Analysis of therapeutic efficacy of advanced non-small cell lung cancer treated with Nituzumab versus Anlotinib radiochemotherapy
[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2025, 18(02): 231-235.
|
[4] |
Xinchao Cao, Yongfeng Ma, Ping Ma, Lijun He, Rongjing Xie.
Analysis of programmed death ligand 1 expression in non-small cell lung cancer during perioperative period
[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2025, 18(02): 251-255.
|
[5] |
Qiushuang Ma, Minghan Yang, Yaolin Wang, Yingying Lan, Ziteng Liu, Jingku Zhang.
Expression and clinical significance of serum exosomal human microRNA-195-5p in non-small cell lung cancer
[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2025, 18(02): 261-265.
|
[6] |
Zhijing Liu, Jing Ma, Liying Wang, Peng Li, Yanan Zhang, Tongzhen Chen.
Status and influencing factors of cancer-related fatigue in patients with end-stage lung cancer
[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2025, 18(02): 310-314.
|
[7] |
Lili Zhang, Feng Xu, Xunpeng Xie, Xueliang Zhang, Honghua Ji, Wenfei Ji.
Clinical application of bevacizumab as adjuvant chemotherapy for non-small cell lung cancer
[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2025, 18(02): 284-288.
|
[8] |
Xia Wang, Gaofeng Yuan, Guangli Bian, Huijun Jia, Guang Han, Zhen Song, Zhugen Cao.
Clinical significance of ctDNA in predicting recurrence risk of non-small cell lung cancer after adjuvant chemotherapy
[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2025, 18(02): 266-272.
|
[9] |
Kejia Yang, Qi Sun, Weifeng Qu, Yuan Weng, Qichen Cui, Jinyou Li.
Clinical application of Flex-3D thoracoscopic lobectomy in non-small cell lung cancer
[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2025, 18(01): 62-67.
|
[10] |
Qiao Lv, Qian Min, Lu Jiang, Qian Chen, Jin Peng, Qian Dai.
Effect of overexpression of KLF7 on proliferation and apoptosis of human non-small cell lung cancer cells
[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2025, 18(01): 1-7.
|
[11] |
Yan Liu, Peiyan Zhao, Lin Tian, Heran Cui, Na Di, Hui Li, Ying Cheng.
Anti-tumor activity and mechanism of the novel OX40 antibody agonist in humanized mouse NSCLC model
[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2024, 17(06): 901-906.
|
[12] |
Pengfei Xie, Jia Chen, Xiaodong Zhang, Chunrong Zhang, Feng Xu.
Clinical analysis of lobar emphysema ratio for predicting persistent air leakage after video-assisted thoracoscopic lobectomy in NSCLC
[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2024, 17(06): 907-912.
|
[13] |
Qian Zheng, Yan Xu, Yanlu Xiong, Yang Liu, Yongfu Ma.
Comparison of anatomical subsegment-based precise lung resection versus lobectomy in the treatment of stage IA1-IA2 lung adenocarcinoma
[J]. Chinese Journal of Laparoscopic Surgery(Electronic Edition), 2025, 18(01): 32-37.
|
[14] |
Lan Li, Wei Mo, Qing Wang, Qin Hu, Qin Li, Yaqin Wu, Chenglin Luo.
Application of hospital-community-family integrated management model for VTE prevention among community elderly people
[J]. Chinese Journal of Interventional Radiology(Electronic Edition), 2025, 13(01): 88-92.
|
[15] |
Danwen Zhao, Dandan Liu, Wendeng Li, Ranran Kong, Shiyuan Liu.
Impact of adjuvant chemotherapy on survival for patients with completely resected stage T2bN0M0 non-small cell lung cancer
[J]. Chinese Journal of Thoracic Surgery(Electronic Edition), 2025, 12(01): 12-23.
|